Commercialization of Prescript-Assist(tm), our flagship product, has now been formalized with the June 2005 publication of a double-blind cross-over clinical trial for the Treatment of Irritable Bowel Syndrome (IBS) (Bittner, Croffit & Stranahan, 2005) by Clinical Therapeutics: The International Peer-Reviewed Journal of Drug Therapy.
Bottle Count - 30 count and 550 mgs.
Prescript-Assist(tm) | 60 Count
Commercialization of Prescript-Assist(tm), our flagship product, has now been formalized with the June 2005 publication of a double-blind cross-over clinical trial for the Treatment of Irritable Bowel Syndrome (IBS) (Bittner, Croffit & Stranahan, 2005) by Clinical Therapeutics: The International Peer-Reviewed Journal of Drug Therapy.
Bottle Count - 60 count and 550 mgs.
Prescript-Assist(tm) | 90 Count
Commercialization of Prescript-Assist(tm), our flagship product, has now been formalized with the June 2005 publication of a double-blind cross-over clinical trial for the Treatment of Irritable Bowel Syndrome (IBS) (Bittner, Croffit & Stranahan, 2005) by Clinical Therapeutics: The International Peer-Reviewed Journal of Drug Therapy.
